Dinney CPN - Search Results

1

A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer.

Campbell MT, Shah AY, Msaouel P, Tannir NM, Siefker-Radtke AO, Kamat AM, Navai N, Dinney CPN, Rao P, Guo CC, Sheth RA, Venkatesan AM, Tidwell RS, Yadav SS, Gu A, Chen H, Macaluso M, Duan F, Basu S, Jindal S, Sharma P. Campbell MT, et al. Among authors: dinney cpn. Cancer Res Commun. 2024 Sep 1;4(9):2444-2453. doi: 10.1158/2767-9764.CRC-24-0237. Cancer Res Commun. 2024. PMID: 39207194 Free PMC article.

2

Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.

Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC. Pollack A, et al. Cancer. 1994 Nov 15;74(10):2819-27. doi: 10.1002/1097-0142(19941115)74:10<2819::aid-cncr2820741013>3.0.co;2-l. Cancer. 1994. PMID: 7954243 Clinical Trial.

3

Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model.

Kleinerman DI, Dinney CP, Zhang WW, Lin SH, Van NT, Hsieh JT. Kleinerman DI, et al. Cancer Res. 1996 Aug 1;56(15):3431-5. Cancer Res. 1996. PMID: 8758907

4

Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.

Dinney CP, Bielenberg DR, Perrotte P, Reich R, Eve BY, Bucana CD, Fidler IJ. Dinney CP, et al. Cancer Res. 1998 Feb 15;58(4):808-14. Cancer Res. 1998. PMID: 9485039

5

Rationale for bladder-sparing surgery in patients with locally advanced colorectal carcinoma.

Balbay MD, Slaton JW, Trane N, Skibber J, Dinney CP. Balbay MD, et al. Cancer. 1999 Dec 1;86(11):2212-6. doi: 10.1002/(sici)1097-0142(19991201)86:11<2212::aid-cncr6>3.0.co;2-2. Cancer. 1999. PMID: 10590359

6

Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.

Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, Radinsky R, Dinney CP. Inoue K, et al. Cancer Res. 2000 Apr 15;60(8):2290-9. Cancer Res. 2000. PMID: 10786697

7

Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.

Inoue K, Slaton JW, Davis DW, Hicklin DJ, McConkey DJ, Karashima T, Radinsky R, Dinney CP. Inoue K, et al. Clin Cancer Res. 2000 Jul;6(7):2635-43. Clin Cancer Res. 2000. PMID: 10914704

8

Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8.

Karashima T, Sweeney P, Kamat A, Huang S, Kim SJ, Bar-Eli M, McConkey DJ, Dinney CP. Karashima T, et al. Clin Cancer Res. 2003 Jul;9(7):2786-97. Clin Cancer Res. 2003. PMID: 12855659

9

Efficient therapeutic gene delivery after systemic administration of a novel polyethylenimine/DNA vector in an orthotopic bladder cancer model.

Sweeney P, Karashima T, Ishikura H, Wiehle S, Yamashita M, Benedict WF, Cristiano RJ, Dinney CP. Sweeney P, et al. Cancer Res. 2003 Jul 15;63(14):4017-20. Cancer Res. 2003. PMID: 12874000

10

The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo.

Kamat AM, Karashima T, Davis DW, Lashinger L, Bar-Eli M, Millikan R, Shen Y, Dinney CP, McConkey DJ. Kamat AM, et al. Mol Cancer Ther. 2004 Mar;3(3):279-90. Mol Cancer Ther. 2004. PMID: 15026548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters